Project Funded by

Project

The EChiLiBRiST project aims to develop and validate a rapid point-of-care test for measuring biomarkers of severity in children with fever, enabling better risk stratification and improved survival outcomes in low-income countries. Funded by the European Union’s Horizon Europe research and innovation programme, this five-year project involves designing the diagnostic device, conducting clinical trials in Ethiopia, Gabon, and Mozambique, and evaluating the intervention’s cost-effectiveness and acceptability.

ITClinical’s role in the project

ITClinical's added value for the consortium is of utmost importance for the EchiLiBRiST project, in particular in the management and monitoring of the clinical trials. On one hand, our skilled and well-trained clinical staff provides the highest quality monitoring work, following the protocol-specific requirements and international guidelines (ICH and GCP), to ensure the ethical conduct of the study, the accuracy and completeness of the recorded data required to maximise the scientific validity of the study. On the other hand, ITClinical brings its proprietary Pharmacovigilance and Clinical Trial Logistics and Management systems, based on over 15 years of experience in software development and validation in regulated environments. The configuration and customisation of the software will significantly impact the clinical trials and contribute to a more efficient and optimised study.